Ernst Berndt

1

Article

0

Comments
Heather Bresch, CEO of Mylan, holds two EpiPens as she testified before Congress Sept. 21, 2016 about rising costs of the drug. AP Photo/Pablo Martinez Monsivais

Hospitals hit back on drug pricing, but will they knock out the problem?

Ernst Berndt, MIT Sloan School of Management

The rising costs of generic drugs have led to outcries. In a search for solutions, four hospital systems are proposing to make drugs on their own. Could their idea work?

Contact Ernst for

  • General
  • Media request
  • Speaking request
  • Consulting / Advising
  • Research collaboration
  • Research supervision
  • Location: Cambridge, Massachusetts
  • Article Feed
  • Joined